Shares of Marksans Pharma rallied over 9% to Rs 306.20 apiece on the BSE on Wednesday after the company reported a 174% year-on-year surge in its Q1 profit after tax to Rs 159 crore, from Rs 58 crore in the corresponding quarter of the previous year.
The pharmaceutical company released its Q1 results for this year on Wednesday, in a regulatory filing on the BSE. The company’s EBITDA stood at an all-time quarterly high at Rs 213 crore, rising 113% year-on-year from Rs 100 crore in the same quarter last year.